Suramin sodium is an antiparasitic agent used primarily in the parenteral treatment of African trypanosomiasis and onchocerciasis, often acting to inhibit the migration of adult worms and microfilariae… Read more
Suramin sodium is an antiparasitic agent used primarily in the parenteral treatment of African trypanosomiasis and onchocerciasis, often acting to inhibit the migration of adult worms and microfilariae by interfering with host cell metabolism. Analytical laboratories requiring precise quantification and identification of this compound rely on high-quality reference standards for method development, validation, and routine quality control. This collection includes the active pharmaceutical ingredient alongside critical degradation products and impurities, such as 8-amino-1,3,5-naphthalenetrisulfonic acid trisodium salt, essential for impurity profiling during stability studies. Additionally, the availability of stable isotope labelled compounds, including Suramin-d12 sodium salt, provides investigators with vital internal standards to enhance accuracy in complex mass spectrometry-based assays. These materials support rigorous testing protocols, ensuring compliance with regulatory standards for pharmaceutical development and monitoring.